Pricing Experts Offer Insight Into Use of Advanced Analytics, Note 85% of Companies Lack Sufficient Data or Detailed Pricing Information
85% of interviewed companies lack sufficient data, price quality, or price transparency information to be able to properly apply advanced [...]
2021 Global Medical Affairs Outsourcing Market Research Report Details 2028 Outlook
HealthCare Intelligence has released a report analyzing worldwide trends relating to healthcare outsourcing markets using primary and secondary methods along [...]
New Bills Propose High Taxes for Unjustified Drug Price Increases
Legislators in Washington and Hawaii have introduced bills aimed at drug price increases by pharmaceutical companies. Should these bills be [...]
Aetna Return to ACA Exchanges Reflects Industry-Wide Trend Amid COVID-19 Relief Package Boost
The Aetna insurance division of the CVS Health Corp. will return to the ACA (Affordable Care Act) exchanges in 2022. [...]
A Discussion with Paul Perreault of CSL Limited on COVID-19
Paul Perreault is CEO and Managing Director of CSL Limited, a top three global biotech company. He was invited to [...]
Will ‘All of Us’ Bring Positive Change to Research?
“All of Us” is the $1.5 billion initiative led by the federal government with the purpose of collecting health data from [...]
Google Reveals Care Studio Tool for Providers
Google has piloted a new search tool for electronic medical records called Care Studio. In the trial phase, around 250 [...]
IBM’s Watson AI Technology Falls Short of Potential
A decade ago, IBM (International Business Machine Corporation) used its AI (artificial intelligence) technology system termed Watson to beat people [...]
NBER Releases Cost-Sharing Report: Drug Price Increases Associated With Increased Mortality
The National Bureau of Economic Research (NBER) has released a report on how cost-sharing affects patient care. The authors found [...]
Datavant Seeks to Improve Data Sharing
Datavant seeks to streamline data sharing across platforms while maintaining privacy. Datavant has recently announced partnerships with specialty hub providers, [...]
Epidemiologists Build COVID-19 Data Platform—With Help From Google
In January of 2020, Samuel Scarpino, director of the Emergent Epidemics Lab at Northeastern University, started inputting data in a [...]
CDC Introduces VaccineFinder
In an effort to provide the public with information regarding COVID-19 vaccine availability, the CDC has released VaccineFinder, an online [...]
Republicans Criticize Biden’s Health Secretary Pick
Biden’s pick for health secretary, Xavier Becerra, currently serving as attorney general in California, has not been welcomed by Republican [...]
Aetion Vice President of Growth and Strategic Partnerships Discusses RWE
Ian Rentsch recently became Vice President of Growth and Strategic Partnerships at Aetion. He previously held roles in clinical research [...]
[Workshop] RWE in Regulatory Decision-Making Processes
A recent workshop focusing on RWE (real world evidence) explored the role in observational studies in determining drug effectiveness and [...]
[Webinar] RWE in Drug Development
Dr. Nicolle Gatto of Aetion, along with leaders from Sanofi and Janssen, will discuss the use of RWE (real world [...]
Understanding the Impact of COVID-19 on SDoH
COVID-19 has wreaked havoc across countless sectors and populations and has also deepened the social determinant risk. A new eBook [...]
Panalgo Releases RWD Benchmarking Report
Healthcare analytics company Panalgo released its 2021 State of Healthcare Analytics Benchmarking Report, featuring insight into the use of RWD [...]
Icon Acquires PRA Health Sciences for $12 Billion
The use of decentralized trials has surged during COVID-19. CRO (contract research organization) Icon is set to acquire PRA Health [...]
Reference Pricing Could Negatively Affect Vulnerable Populations
Some countries use QALYs (Quality-Adjusted Life Years) to assess whether or not to use a treatment or prescription drug. The [...]
Webinar on Providing Meaningful Price Transparency Information
In order to comply with recent rulings, many organizations are sharing large amounts of data. However, not all data is [...]
Using RWE to Make Cost Decisions: A New Report
A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world evidence) can be utilized when making economic decisions. ICER (the Institute for Clinical and Economic Review) has incorporated RWE in making its recommendations, but few other organizations have been as ready to make such a move.
Payer Engagement Summit Videos on RWD Now Available
ISPOR held its first Payer Engagement Summit in 2020 to discuss the issues facing payers worldwide. The Summit featured discussions [...]
COVID-19 CARE Registry Provides Informative Data
Dr. Nancy Dreyer is the Chief Scientific Officer of IQVIA Real World Solutions. In a recent interview led by Dr. [...]
Syapse Invests $68 Million in Expanding RWE to Improve Outcomes for Cancer Patients
Leading RWE (real world evidence) company Syapse has invested $68 million in a venture with Ally Bridge Group and Northpond [...]